DelveInsight Business Research LLP As per DelveInsight’s assessment, about 40+ key pharma and biotech companies are working on 45+ pipeline drugs in the Janus kinase (JAK) inhibitors Competitive landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]
